Your SlideShare is downloading. ×
0
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
10 midcap stocks for gains in this volatile market
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

10 midcap stocks for gains in this volatile market

236

Published on

Dolat Capital has upgraded stance on the Indian market to neutral, led by significant improvement in factors that turned their opinion to negative. Here are a 10 midcap stocks for gains in this …

Dolat Capital has upgraded stance on the Indian market to neutral, led by significant improvement in factors that turned their opinion to negative. Here are a 10 midcap stocks for gains in this volatile market

Read more at: http://ow.ly/rg6Sn

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
236
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. 10 midcap stocks for gains in this volatile market
  • 2. • Dolat Capital has upgraded stance on the Indian market to neutral, led by significant improvement in factors that turned their opinion to negative. According to the brokerage firm, sharp drop in the gold imports, softening oil prices and temporary extension of timeline of US tapering has given enough fire power for the markets to move up sharply. It feels that current liquidity-led rally will need stronger legs to sustain. This can be sustained only by growth in earnings, wider participation of stocks and outcome of the general election scheduled next year. As the market plays catch-up, Dolat Cap recommends 10 midcap stocks that you can buy or accumulate and gain around 33% in the longterm.
  • 3. • • • • Biocon Rating: ACCUMULATE BSE: 532523 | NSE: BIOCON Target: Rs 399 Upside: 9% Rationale: Biopharma and contract research segment is expected to grow by 15% and 21% over FY13-15E. Strategic partnerships with BMS/Mylan ensures higher visibiltiy in earnings going forward. Anticipate 24% earnings growth over FY13-15E.
  • 4. • • • • Karur Vysya Bank Rating: BUY BSE: 590003 | NSE: KARURVYSYA Target: Rs 430 Upside: 33% Rationale: Delinquency rates still lower than industry. Decline in NIM was sharp, expect to improve in 2HFY14.
  • 5. • • • • Amara Raja Batteries Rating: ACCUMULATE BSE: 500008 | NSE: AMARAJABAT Target: Rs 355 Upside: 6% Rationale: Huge replacement demand to drive growth. Huge capex to augur volumes
  • 6. • • • • Berger Paints India Rating: ACCUMULATE BSE: 509480 | NSE: BERGEPAINT Target: Rs 235 Upside: 2% Rationale: Gap between Asian Paints and Berger Paints has widened. Premiumisation strategy has played out well for the company which has resulted in an improvement in operating margins.
  • 7. • • • • Rating: BUY Indraprastha Gas BSE: 532514 | NSE: IGL Target: Rs 344 Upside: 26% Rationale: Not impacted by change in allocation of domestic gas to city gas distributors (CGDs) sector. Ability to maintain gross spreads though the gas cost is increasing. Current price seems to factoring the extreme negatives of the ongoing legal case with PNGRB.
  • 8. • • • • KPIT Technologies Rating: BUY BSE: 532400 | NSE: KPIT Target: Rs 185 Upside: 27% Rationale: Sustained strong volume traction. Volumes up 2%; Pricing up 1%. Demand momentum strong across SBUs. EBIT Margin down in Q2FY14.
  • 9. • • • • Supreme Industries Rating: ACCUMULATE BSE: 509930 | NSE: SUPREMEIND Target: Rs 448 Upside: 14% Rationale: Extensive range of products enabling SIL to play plastic consumption story. Ability to innovate and bring new plastic products in the market. Brand focus gives pricing power and increasing share of value added products.
  • 10. • • • • Ipca Laboratories Rating: ACCUMULATE BSE: 524494 | NSE: IPCALAB Target: Rs 785 Upside: 16% Rationale: Revenue growth of 20% and EBITDA margin at 2324% for FY14e. Indore SEZ plant to contribute inFY15E. Institutional business to contribute Rs 4.5bn in FY14E and Rs 5.0bn in FY15e.
  • 11. • • • • City Union Bank Rating: BUY BSE: 532210 | NSE: CUB Target: Rs 61 Upside: 29% Rationale: The rise in fresh NPL formations only temporary, overall asset quality much better than industry. Agility to hold on to the margins even in turbulent times.
  • 12. • • • • PI Industries Rating: ACCUMULATE BSE: 523642 | NSE: PIIND Target: Rs 240 Upside: 33% Rationale: Favorable portfolio mix to aid margin expansion backed by high visibility in CSM business. Anticipate 32% revenue growth over FY13-15E. Sustenance of elevated return ratios likely as new capacities turn accretive.

×